Johns Hopkins Bloomberg School of Public Health experts Nicole Baumgarth and Thomas Hart discuss ticks and the growing threat of Lyme and other tickborne diseases.
Lyme disease is on the rise in the U.S., according to the CDC, mainly in the Northeast, Upper Midwest, and parts of the West. In 2023, state health departments reported more than 89,000 cases of Lyme disease in humans to the CDC, but the actual number of cases is likely much higher due to underreporting and misdiagnosis.
If left untreated, Lyme disease can lead to serious complications affecting the heart, joints, and nervous system. Other tickborne illnesses are also of concern, including Powassan virus and Heartland virus. There is currently no vaccine against tickborne illnesses.
Sadly, researchers continue to slice and dice this complex illness into a singular infection they call ‘Lyme disease,’ when truth be told, patients are often infected with numerous things working synergistically together, making the illness much more complex, harder to identify and treat, and much harder to overcome. So the very name, ‘Lyme disease,’ is inadequate for most patients.
I realize why they do this: due to their very specific work, they must omit variables to conduct research – at least within the current allopathic model of one drug and vaccine, for one disease. Unfortunately, this is often not what we are dealing with at all in reality.
• Lyme and Tickborne Diseases Research and E… 
Madison Area Lyme Support Group 